Interventional Cardiology & Vascular Practice Database

The cardiovascular intervention market is one of the fastest-growing in medicine, driven by transformative innovations in structural heart (TAVR, mitral valve repair), expanding peripheral vascular indications, and technology-intensive procedures that generate substantial revenue. These practices are active, high-volume purchasers of stents, catheters, imaging systems, cath lab equipment, and ancillary services.

Market Overview

The US interventional cardiology and vascular market generates approximately $35 billion annually and continues to grow driven by aging demographics, expanded device indications, and structural heart innovation. The total addressable market for vendors selling to interventional cardiology practices includes:

• Coronary stents and catheters: $6 billion annually
• Structural heart devices (TAVR, mitral repair): $5 billion (growing 15%+ annually)
• Peripheral vascular devices: $4 billion
• Cardiac imaging and cath lab equipment: $3 billion
• Intravascular imaging (IVUS, OCT, FFR): $1.5 billion
• Cardiovascular pharmaceuticals: $15 billion (antiplatelets, anticoagulants, lipid therapies)

The specialty is experiencing rapid technology adoption, with structural heart programs and peripheral vascular services expanding across community hospitals that previously referred complex cases.

Practice Landscape

• Practice Types:
• **Hospital-based programs (55%)** - Interventional cardiologists employed by health systems, decisions influenced by hospital purchasing committees and GPOs
• **Large cardiology groups (25%)** - Multi-physician practices with owned or jointly-owned cath labs, centralized purchasing, high procedure volumes
• **Vascular surgery practices (12%)** - Endovascular-focused groups, often independent, strong growth in office-based labs
• **Academic medical centers (8%)** - Teaching institutions with structural heart programs, early adopters of new technology, clinical trial sites

• Ownership Models:
• Hospital employment is the dominant model due to capital-intensive nature of cath labs
• Physician-owned practices common in vascular surgery and outpatient cardiology
• Office-based labs (OBLs) growing rapidly, particularly for peripheral vascular and venous procedures
• Private equity interest emerging in outpatient cardiac catheterization

• Facility Types:
• Hospital cardiac catheterization labs (majority of PCI volume)
• Ambulatory surgery centers with cardiac capabilities
• Office-based labs (fastest-growing segment for peripheral/venous)
• Hybrid OR suites for structural heart procedures

• Geographic Distribution:
• Highest concentration in major metropolitan areas with cardiac surgery backup
• Florida, Texas, California, and the Northeast have the most practices
• Structural heart programs concentrated in larger hospitals and academic centers
• Peripheral vascular services more widely distributed

Key Decision Makers

• Physician Leadership:
• **Interventional cardiologists** control device selection and influence capital equipment decisions
• **Cath lab medical directors** oversee equipment, protocols, and vendor access
• **Structural heart program directors** drive TAVR/mitral device selection
• **Peripheral/vascular specialists** control growing outpatient intervention market

• Hospital Administration:
• **CV service line directors** manage budget and strategic planning
• **Cath lab managers** oversee day-to-day operations and supply ordering
• **VP of cardiovascular services** controls large capital purchases
• **Chief medical officers** influence hospital-wide vendor contracts

• Purchasing Influencers:
• Cath lab nurses and technologists influence accessory and consumable selection
• Cardiac imaging specialists (echo, CT) affect imaging equipment decisions
• Heart failure cardiologists influence structural heart program development
• Vascular medicine physicians direct peripheral vascular referrals

What's In Our Database

Our interventional cardiology practice database includes comprehensive information for targeted sales and marketing outreach:

• Practice Information:
• Practice name and DBA
• Complete address (street, city, state, ZIP)
• Phone and fax numbers
• Website URL
• Practice email addresses
• Hospital affiliations and privileges
• Cath lab locations

• Provider Details:
• Physician names and credentials (MD, DO)
• NPI numbers
• Board certifications (ABIM cardiovascular, interventional cardiology)
• Fellowship training (structural heart, peripheral vascular)
• State medical licenses
• Hospital privileges

• Practice Intelligence:
• Procedure focus (coronary, structural, peripheral mix)
• Cath lab capabilities and technology
• Structural heart program status
• Estimated procedure volumes
• Number of interventionalists and support staff
• Office-based lab presence

• Contact Information:
• Cath lab manager names
• Practice administrator contacts
• Scheduling coordinator contacts
• Direct phone extensions

Use Cases

Industry Statistics

• Market Metrics:
• $35 billion annual US interventional cardiology market
• 6,000+ interventional cardiology practices
• 8,500+ interventional cardiologists
• 600,000 PCI procedures annually
• 80,000+ TAVR procedures annually
• 500,000+ peripheral vascular interventions annually

• Procedure Economics:
• Average PCI case value: $15,000-$25,000 (devices and supplies)
• Average TAVR case value: $50,000-$75,000
• Average peripheral intervention: $8,000-$20,000
• Drug-eluting stent: $1,200-$2,500 per stent
• TAVR valve: $32,500 average

• Growth Trends:
• TAVR volume growing 15%+ annually
• Mitral valve repair emerging as next structural heart growth driver
• Office-based labs for peripheral vascular growing 20%+ annually
• Intravascular imaging adoption expanding beyond academic centers
• Radial access now standard (60%+ of PCI)

• Technology Adoption:
• Robotic PCI systems in early adoption at high-volume centers
• IVUS/OCT used in 25-30% of complex PCI
• FFR/iFR physiology-guided intervention standard of care
• Same-day discharge protocols expanding for elective PCI

Why Target Interventional Cardiology Practices

Highest Device Spend Per Procedure - Interventional cardiology has the highest consumable costs in medicine. A single TAVR procedure uses $32,500+ in devices. PCI cases average $3,000-$5,000 in stents and accessories.

Rapid Technology Adoption - Interventional cardiologists are early adopters. Structural heart, intravascular imaging, and robotic systems represent continuous upgrade cycles and new product opportunities.

Growing Procedure Volumes - TAVR is growing 15%+ annually. Peripheral vascular interventions expanding. Office-based labs creating new access points for outpatient procedures.

Capital Equipment Refresh Cycles - Cath labs require regular equipment upgrades. Imaging systems, tables, and monitoring equipment represent significant capital budget opportunities every 7-10 years.

Recurring Consumable Revenue - Every procedure requires catheters, guidewires, contrast, and accessories. High-volume labs place regular orders creating predictable revenue streams.

Hospital Priority Service Line - Cardiovascular services generate significant hospital revenue. CV service lines receive investment priority, creating budget for new technology and equipment.

Frequently Asked Questions